Zhou YN - Search Results

1

Correlations of P21-activated kinase 1 expression to clinicopathological features of gastric carcinoma and patients' prognosis.

Wang JX, Zhou YN, Zou SJ, Ren TW, Zhang ZY. Wang JX, et al. Among authors: zhou yn. Chin J Cancer. 2010 Jul;29(7):649-54. doi: 10.5732/cjc.009.10709. Chin J Cancer. 2010. PMID: 20591216

2

Expression of E-cadherin and beta-catenin in gastric carcinoma and its correlation with the clinicopathological features and patient survival.

Zhou YN, Xu CP, Han B, Li M, Qiao L, Fang DC, Yang JM. Zhou YN, et al. World J Gastroenterol. 2002 Dec;8(6):987-93. doi: 10.3748/wjg.v8.i6.987. World J Gastroenterol. 2002. PMID: 12439911 Free PMC article.

3

[Relationship between abnormal expression of beta-catenin in gastric carcinoma and survival].

Zhou YN, Li M. Zhou YN, et al. Ai Zheng. 2002 May;21(5):536-40. Ai Zheng. 2002. PMID: 12452049 Chinese.

4

Alpha-catenin expression is decreased in patients with gastric carcinoma.

Zhou YN, Xu CP, Chen Y, Han B, Yang SM, Fang DC. Zhou YN, et al. World J Gastroenterol. 2005 Jun 14;11(22):3468-72. doi: 10.3748/wjg.v11.i22.3468. World J Gastroenterol. 2005. PMID: 15948257 Free PMC article.

5

[CpG island methylation of E-cadherin gene promoter in gastric carcinoma].

Zhou YN, Xu CP, Han B, Ji R. Zhou YN, et al. Ai Zheng. 2005 Oct;24(10):1220-4. Ai Zheng. 2005. PMID: 16219136 Chinese.

6

Effect of celecoxib on E-cadherin, VEGF, Microvessel density and apoptosis in gastric cancer.

Zhou Y, Ran J, Tang C, Wu J, Honghua L, Xingwen L, Ning C, Qiao L. Zhou Y, et al. Cancer Biol Ther. 2007 Feb;6(2):269-75. doi: 10.4161/cbt.6.2.3629. Epub 2007 Feb 26. Cancer Biol Ther. 2007. PMID: 17224647 Clinical Trial.

7

A rising trend of gastric cardia cancer in Gansu Province of China.

Zhou Y, Zhang Z, Zhang Z, Wu J, Ren D, Yan X, Wang Q, Wang Y, Wang H, Zhang J, Zhu X, Yang Y, Luo C, Guo X, Tang C, Qiao L. Zhou Y, et al. Cancer Lett. 2008 Sep 28;269(1):18-25. doi: 10.1016/j.canlet.2008.04.013. Epub 2008 May 22. Cancer Lett. 2008. PMID: 18501504

8

[Celecoxib induces apoptosis and inhibits angiogenesis in gastric cancer].

Ran JT, Zhou YN, Tang CW, Lu JR, Wu J, Lu H, Yang GD. Ran JT, et al. Among authors: zhou yn. Zhonghua Zhong Liu Za Zhi. 2008 Jun;30(6):448-51. Zhonghua Zhong Liu Za Zhi. 2008. PMID: 19024521 Clinical Trial. Chinese.

9

[Expression of cyclooxygenase-2 and urokinase plasminogen activator in gastric carcinoma and the clinical significance thereof].

Zhang FH, Zhou YN, Li GZ, Li Q, Lu B, Zhang ZY, Wu ZQ, Fan P, Hao TJ. Zhang FH, et al. Among authors: zhou yn. Zhonghua Yi Xue Za Zhi. 2008 Dec 16;88(46):3279-82. Zhonghua Yi Xue Za Zhi. 2008. PMID: 19159555 Chinese.

10

[Short-term preoperative treatment of celecoxib, a selective cyclooxygenase-2 inhibitor, on E-cadherin expression in gastric carcinoma tissues].

Ran JT, Zhou YN, Tang CW, Li HH, Li XW, Lu H. Ran JT, et al. Among authors: zhou yn. Ai Zheng. 2009 Apr;28(4):361-5. Ai Zheng. 2009. PMID: 19622294 Clinical Trial. Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results